miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054507 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Bonita H Powell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, MicroRNAs, Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Johns Hopkins Catalyst.
Abstract (Originalsprache)
Hypoxia, or low oxygen tension, is frequently found in highly proliferative solid tumors such as anaplastic thyroid carcinoma (ATC) and is believed to promote resistance to chemotherapy and radiation. Identifying hypoxic cells for targeted therapy may thus be an effective approach to treating aggressive cancers. Here, we explore the potential of the well-known hypoxia-responsive microRNA (miRNA) miR-210-3p as a cellular and extracellular biological marker of hypoxia. We compare miRNA expression across several ATC and papillary thyroid cancer (PTC) cell lines. In the ATC cell line SW1736, miR-210-3p expression levels indicate hypoxia during exposure to low oxygen conditions (2% O2). Furthermore, when released by SW1736 cells into the extracellular space, miR-210-3p is associated with RNA carriers such as extracellular vesicles (EVs) and Argonaute-2 (AGO2), making it a potential extracellular marker for hypoxia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Division of Cancer Genome Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
- Heidelberg Biolabs GmbH, 69120 Heidelberg, Germany.
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA.
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
ORCID-Profile: Andrey Turchinovich, Olesia Gololobova, Dominik Buschmann
Förderung
- NCI NIH HHS
- Johns Hopkins Catalyst
Zitieren
APA
Powell, B. H., Turchinovich, A., Wang, Y., Gololobova, O., Buschmann, D., Zeiger, M. A., Umbricht, C. B., & Witwer, K. W. (2023). miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054507
Vancouver
Powell BH, Turchinovich A, Wang Y, Gololobova O, Buschmann D, Zeiger MA, et al. miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054507
BibTeX
@article{Powell2023,
author = {Powell, Bonita H and Turchinovich, Andrey and Wang, Yongchun and Gololobova, Olesia and Buschmann, Dominik and Zeiger, Martha A and Umbricht, Christopher B and Witwer, Kenneth W},
title = {miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054507}
}
EUVIMED